The Greater Cannabis Company, Inc. (GCAN)
OTCMKTS · Delayed Price · Currency is USD
0.2090
0.00 (0.00%)
At close: Apr 14, 2026
GCAN Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
197.49K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 12.63K | -35.41K | -73.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| StateHouse Holdings | 103.72M |
| Ecofibre | 17.56M |
| Petros Pharmaceuticals | 5.11M |
| Stemtech | 3.73M |
| CannLabs | 1.72M |
| BioTech Medics | 469.80K |
| Neutra | 66.07K |
| Pineapple Express Cannabis Company | 4.33K |
The Greater Cannabis Company News
- 4 months ago - GCANRx Announces Relisting To OTCQB Market Tier - GlobeNewsWire
- 10 months ago - GCANRx Announces Uplisting to New Market Tier - GlobeNewsWire
- 1 year ago - GCAN to Explore Strategic Alternatives in Artificial Intelligence and Quantum Computing - GlobeNewsWire
- 2 years ago - GCANRx Announces Completion of Preclinical Study for Neuropsychiatric Cannabinoid Therapy - GlobeNewsWire
- 2 years ago - GCANRx Featured in American Journal of Endocannabinoid Medicine - GlobeNewsWire
- 3 years ago - GCANRx Announces Approval of Phase II Clinical Trial to Treat Autism Related Spectrum Disorders - GlobeNewsWire
- 3 years ago - GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders - GlobeNewsWire
- 4 years ago - GCANRx Strategic Advisor Dr. Adi Aran to be Interviewed by Dr. Sanjay Gupta on CNN Cannabis Special - GlobeNewsWire